Almatica Pharma, Inc. a subsidiary of Alvogen, is focused on the acquisition of brand Rx products. Established in 2008, Almatica Pharma has a current portfolio that includes Pain, Urology and nonsteroidal anti-inflammatory drugs (NSAIDs). Almatica is led by an experienced brand pharmaceutical management team and our current operations consist of established systems to support all aspects of brand product management including r...
Almatica Pharma, Inc. a subsidiary of Alvogen, is focused on the acquisition of brand Rx products. Established in 2008, Almatica Pharma has a current portfolio that includes Pain, Urology and nonsteroidal anti-inflammatory drugs (NSAIDs). Almatica is led by an experienced brand pharmaceutical management team and our current operations consist of established systems to support all aspects of brand product management including regulatory affairs, sales, marketing, customer service, and pharmacovigilance.
The parent company of Almatica, Alvogen, is a multinational, privately owned pharmaceuticals company. Alvogen is focused on building the next-generation pharmaceuticals organization through the strategic selection of products, partners and markets, and the utilization of an effective consolidated global supply chain. Alvogen’s product portfolio consists of a broad range of leading molecules for the treatment of conditions in the areas of oncology, cardiology, respiratory, neurology and gastroenterology. Alvogen has first-class regulatory, development and manufacturing capabilities in Asia, Europe and North America.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.